Discontinuation of SGLT-2i and GLP-1RA among persons with Type 2 diabetes and atherosclerotic cardiovascular disease treated in US cardiology clinics.
- DOI
- 10.1016/j.ahj.2024.12.006
- Published
- 2025 Apr
- Container
- American heart journal
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ahj.2024.12.006,
title = {Discontinuation of SGLT-2i and GLP-1RA among persons with Type 2 diabetes and atherosclerotic cardiovascular disease treated in US cardiology clinics.},
author = {Nelson AJ and Kaltenbach LA and McGuire DK and Levya M and Al-Khalidi HR and Webb L and Lopes RD and Pop-Busui R and Cavender MA and Aroda VR and Magwire ML and Richardson CR and Lingvay I and Kirk JK and Pandey A and Gaynor T and Pak J and Washington A and Senyucel C and Green JB and Granger CB and Pagidipati NJ},
year = {2025},
journal = {American heart journal},
doi = {10.1016/j.ahj.2024.12.006},
url = {https://doi.org/10.1016/j.ahj.2024.12.006}
}RIS
TY - JOUR TI - Discontinuation of SGLT-2i and GLP-1RA among persons with Type 2 diabetes and atherosclerotic cardiovascular disease treated in US cardiology clinics. AU - Nelson AJ AU - Kaltenbach LA AU - McGuire DK AU - Levya M AU - Al-Khalidi HR AU - Webb L AU - Lopes RD AU - Pop-Busui R AU - Cavender MA AU - Aroda VR AU - Magwire ML AU - Richardson CR AU - Lingvay I AU - Kirk JK AU - Pandey A AU - Gaynor T AU - Pak J AU - Washington A AU - Senyucel C AU - Green JB AU - Granger CB AU - Pagidipati NJ PY - 2025 JO - American heart journal DO - 10.1016/j.ahj.2024.12.006 UR - https://doi.org/10.1016/j.ahj.2024.12.006 ER -
APA
AJ, N., LA, K., DK, M., M, L., HR, A., L, W., RD, L., R, P., MA, C., VR, A., ML, M., CR, R., I, L., JK, K., A, P., T, G., J, P., A, W., C, S., JB, G., CB, G., & NJ, P. (2025). Discontinuation of SGLT-2i and GLP-1RA among persons with Type 2 diabetes and atherosclerotic cardiovascular disease treated in US cardiology clinics.. American heart journal. https://doi.org/10.1016/j.ahj.2024.12.006
Source records
- pubmed · retrieved 2026-09-26T19:17:23.401Z